IO Biotech Inc (IOBT) — Financial Flexibility Index
IO Biotech Inc (IOBT) has a Financial Flexibility Index of -0.47x as of September 2025. Free cash flow of $-18.47 Million (operating CF $-18.48 Million minus capex $4.00K) represents 0% of total liabilities ($39.05 Million). Check IOBT goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
IO Biotech Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for IO Biotech Inc across 6 annual periods. For the full cash flow conversion analysis, see IO Biotech Inc cash conversion from operations.
Annual Financial Flexibility Index for IO Biotech Inc (2019–2024)
Year-by-year free cash flow to debt coverage for IO Biotech Inc. Explore IOBT debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.98x | $-82.30 Million | $-82.35 Million | $20.68 Million | ▲ +2.2% |
| 2023 | -4.07x | $-71.41 Million | $-71.74 Million | $17.56 Million | ▲ +10.8% |
| 2022 | -4.56x | $-59.04 Million | $-59.73 Million | $12.95 Million | ▼ -16.7% |
| 2021 | -3.91x | $-40.49 Million | $-40.65 Million | $10.36 Million | ▼ -21.6% |
| 2020 | -3.21x | $-9.80 Million | $-9.96 Million | $3.05 Million | ▼ -300.7% |
| 2019 | -0.80x | $-8.74 Million | $-8.89 Million | $10.89 Million | — |